Han LI, Guang-ping ZHANG, Lei LEI, et al. Toxicological Technology in Evaluation and Application of Traditional Chinese Medicine Healthcare Food[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(6): 201-208.
DOI:
Han LI, Guang-ping ZHANG, Lei LEI, et al. Toxicological Technology in Evaluation and Application of Traditional Chinese Medicine Healthcare Food[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(6): 201-208. DOI: 10.13422/j.cnki.syfjx.20192423.
Toxicological Technology in Evaluation and Application of Traditional Chinese Medicine Healthcare Food
China is rich in herbs that can be used as medicine and food. The application of this kind of traditional Chinese medicine (TCM) as raw material is the basis for guiding the development of TCM healthcare food. TCM healthcare food has advantages in keeping in good health and reducing the risk of disease. At the same time
with the implementation of " Healthy China 2030"
it is urgent to develop a series of herbal compound healthcare food with the characteristics of TCM to meet the national and social needs. With the development of scientific research
however
there is a lack of research on the scientific evaluation of the safety of TCM healthcare food raw materials
which results in insufficient risk assessment theory and technology of healthcare food at present. Therefore
the prediction and evaluation of the toxicity of important components in this kind of raw materials has become an urgent task of food safety. Toxicology plays an important role in human health risk assessment
and its sub-disciplines have been constantly emerging. Computational toxicology
toxicology technology have become important research tools for toxicity prediction and evaluation in this field. With the rapid development of toxicology technology
food safety and human life and health can be effectively guaranteed. It will effectively promote the safety production of healthcare food industry in China and guarantee the quality and safety of terminal products. It has a great social significance
plays a positive leading role in the technological progress of the whole industry
and generates considerable economic benefits. This paper reviews recent advances and applications of new toxicological methods and models for predicting and evaluating important ingredients in TCM healthcare food raw materials.
T LUECHTEFELD , C ROWLANDS , T HARTUNG . Big data and machine learning to revamp computational toxicology and its use in risk assessment [J]. Toxicol Res , 2018 , 7 ( 5 ): 732 - 744 .
S H HUANG , C W TUNG , F FÜLÖP , et al . Developing a QSAR model for hepatotoxicity screening of the active compounds in traditional Chinese medicines [J]. Food Chem Toxicol , 2015 , 78 ( 4 ): 71 - 77 .
A SIVARAMAN , J K LEACH , S TOWNSEND , et al . A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction [J]. Curr Drug Metab , 2005 , 6 ( 6 ): 569 - 591 .
N YAO , D YAO , L WANG , et al . Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression [J]. Tumour Biol , 2012 , 33 ( 5 ): 1767 - 1776 .
E L MICHALETS . Update: clinically significant cytochrome P450 drug interactions [J]. Pharmacotherapy , 1998 , 18 ( 1 ): 84 - 112 .
N J HEWITT , M J LECHÓN , J B HOUSTON , et al . Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins,and pharmaceutical practice for the use of hepatocytes in metabolism,enzyme induction,transporter,clearance,and hepatotoxicity studies [J]. Drug Metab Rev , 2007 , 39 ( 1 ): 159 - 234 .
S WILKENING , F STAHL , A BADER . Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties [J]. Drug Metab Dispos , 2003 , 31 ( 8 ): 1035 - 1042 .
C GUGUEN-GUILLOUZO , A GUILLOUZO . General review on in vitro hepatocyte models and their applications [J]. Methods Mol Biol , 2010 , 640 : 1 - 40 .
J LEE , M J CUDDIHY , N A KOTOV . Three-dimensional cell culture matrices: state of the art [J]. Tisse Eng Part B Rev , 2008 , 14 ( 1 ): 61 - 68 .
F M BENES , N LANGE . Two dimensional versus three-dimensional cell counting: a practical perspective [J]. Trends Neurosci , 2001 , 24 ( 1 ): 11 - 17 .
P GUNNESS , D MUELLER , V SHEVCHENKO , et al . 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies [J]. Toxicol Sci , 2013 , 133 ( 1 ): 67 - 78 .
T KAZUO , K KENJI , N YASUHITO , et al . 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing [J]. Biomaterials , 2013 , 34 ( 7 ): 1781 - 1789 .
B H WEIGL , R BARDELL , C R CABRERA . Lab-on-a-chip for drug development [J]. Adv Drug Deliv Rev , 2003 , 55 ( 3 ): 349 - 377 .
J ELALI , P K SORGER , K F JENSEN . Cells on chips [J]. Nature , 2006 , 442 ( 7101 ): 403 - 411 .
H KIMURA , Y SAKAI , T FUJII . Organ/body-on-a-chip based on microfluidic technology for drug discovery [J]. Drug Metab Pharmacokinet , 2018 , 33 ( 1 ): 43 - 48 .
D M DAMBACH , B A ANDREWS , F MOULIN . New technologies and screening strategies for hepatotoxicity: use of in vitro models [J]. Toxicol Pathol , 2005 , 33 ( 1 ): 17 - 26 .
D KREWSKI , JR D ACOSTA , M ANDERSON , et al . Toxicity testing in the 21 st century: a vision and a strategy [J]. Reprod Toxicol , 2008 , 25 ( 1 ): 136 - 138 .
Analysis of Animal Models with Combined Allergic Rhinitis and Asthma Syndrome in Children Based on Clinical Disease-syndrome Characteristics of Traditional Chinese and Western Medicine
Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics
Establishment and Evaluation of Rat Model of Acute Myocardial Infarction in Coronary Heart Disease with Qi and Yin Deficiency Syndrome Based on Sleep Deprivation Combined with Coronary Artery Ligation
Analysis of Animal Model of Chronic Heart Failure Based on Combination of Diseases and Syndromes of Traditional Chinese Medicine and Western Medicine
Evaluation of Animal Models with Diminished Ovarian Reserve Based on Clinical Disease and Syndrome Characteristics of Traditional Chinese Medicine and Western Medicine
Related Author
CHEN Yuhang
ZHANG Ye
CHEN Hong
ZHANG Ziwei
WU Liqun
HUO Jingwei
HU Longxiao
GAO Jiabei
Related Institution
Dongfang Hospital, Beijing University of Chinese Medicine
Yunnan Provincial Hospital of Traditional Chinese Medicine
School of Clinical Medicine,Beijing University of Chinese Medicine
Beijing Key Laboratory of Chinese Materia Pharmacology,National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases,Institute of Basic Medical Sciences, Xiyuan Hospital,China Academy of Chinese Medical Sciences